Levodopa in Acute Stroke Rehabilitation: Insights from the ESTREL Randomized Clinical Trial
Highlight
– The ESTREL randomized clinical trial examined levodopa’s efficacy as an adjunct to standardized rehabilitation in acute stroke patients with hemiparesis.
– Levodopa, enhancing dopaminergic signaling, did not significantly improve motor function compared to placebo at 3 months, measured by the Fugl-Meyer Assessment.
– Safety profiles were comparable between levodopa and placebo groups, with infections being the most common serious adverse events.
– These findings question the routine use of levodopa in stroke rehabilitation protocols aimed at boosting motor recovery.
Study Background and Disease Burden
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.